<DOC>
	<DOCNO>NCT01431872</DOCNO>
	<brief_summary>The investigator hypothesize decrease estrogen level cause serum DKK1 peak , decrease gradually estrogens reach new low , steady level . The investigator also believe peak DKK1 initiate wave stem cell diversion osteoblastogenic pathway adipogenic pathway . The investigator conduct longitudinal cohort study post menopausal woman hormone-responsive breast cancer treat AIs . The study observe anthromorphic serum marker change first year treatment .</brief_summary>
	<brief_title>Systemic Dickkopf-related Protein 1 ( DKK1 ) During Estrogen Level Changes Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Post Menopausal Breast cancer patient plan treatment aromatase inhibitor . 18 year old BMI &gt; 30 &lt; 18 Osteoporosis define protocol . Subjects currently bisphosphonate therapy . History primary secondary hyperparathyroidism History Hypoor Hyperthyroidism History Vitamin D level LLN History creatinine clearance EGFR History ofLiver function test 1.5 time ULN include LDH , SGOT , SGPT , Alkaline phosphatase , Bilirubin History document cirrhosis liver History chronic heparin use History chronic glucocorticoid therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Aromatase Inhibitors</keyword>
</DOC>